ALPS Medical Breakthroughs ETF SBIO
58.22 USD +0.64 (+1.11%)
At closeNov 11, 2026, 4:00 PM EST
58.22 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
57.20 Day range 58.23
44.80 52-week range 70.85
- YTD
- +13.67%
- 1 year
- +26.37%
News
benzinga.com Kymera Therapeutics Stock Climbs On Accelerated Timeline For Lead Atopic Dermatitis Program Kymera Therapeutics shares surged after completing KT-621 Phase 2b enrollment early, accelerating data timing and Phase 3 plans.
benzinga.com Apogee Stock Slides After Blackstone Financing Deal And Positive Drug Data Apogee shares fell after announcing a $1.3 billion Blackstone financing deal alongside positive Phase 2 eczema drug results.
benzinga.com Structure Therapeutics Stock Explodes As Much-Awaited Experimental Oral Drug Trial Shows Weight Loss Of 16% Structure Therapeutics' Phase 2 ACCESS II trial shows up to 16.3% placebo-adjusted weight loss for obesity drug aleniglipron.
benzinga.com Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ: CMPS) revealed Friday that it has been selected for addition to the Nasdaq Biotechnology Index (NASDAQ: NBI), effective as…
benzinga.com Don't Bail On Biotech ETFs: 'There Are Several Reasons Why The Sector Took A Breather' 
benzinga.com Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy 
benzinga.com Best And Worst ETFs Of The Week Amid Tech Rally - benzinga.com Biotech ETFs Hit New 2015 Highs
benzinga.com The Best And Worst ETFs Of The Week Amid Biotech Rebound - benzinga.com The Best (And Worst) ETFs Of Last Week Amid Social Media's Collapse
- benzinga.com The Best Biotech ETF Isn't Always The Biggest